Terms: = Kidney tumors AND BRAF, MGC126806, 673, ENSG00000157764, MGC138284, RAFB1, P15056, B-raf 1, BRAF1, B-raf1
198 results:
1. Cobimetinib Plus Vemurafenib in Patients With Solid tumors With
Meric-Bernstam F; Rothe M; Mangat PK; Garrett-Mayer E; Gutierrez R; Ahn ER; Cannon TL; Powell S; Krauss JC; Reynolds CM; von Mehren M; Behl D; Calfa CJ; Duvivier HL; Kaplan HG; Livingston MB; Sharma MR; Urba WJ; Grantham GN; Hinshaw DC; Gregory A; Halabi S; Schilsky RL
JCO Precis Oncol; 2023 Sep; 7():e2300385. PubMed ID: 38096472
[TBL] [Abstract] [Full Text] [Related]
2. [Clinicopathological features of adult Wilms tumor with braf V600E mutation].
Gan HL; Wang QF; Zhu XL; Lyu H; Wang J
Zhonghua Bing Li Xue Za Zhi; 2023 Dec; 52(12):1210-1215. PubMed ID: 38058036
[No Abstract] [Full Text] [Related]
3. Management of Brain Metastases: A Review of Novel Therapies.
Bellur S; Khosla AA; Ozair A; Kotecha R; McDermott MW; Ahluwalia MS
Semin Neurol; 2023 Dec; 43(6):845-858. PubMed ID: 38011864
[TBL] [Abstract] [Full Text] [Related]
4. Repurposing AZD5438 and Dabrafenib for Cisplatin-Induced AKI.
Pushpan CK; Kresock DF; Ingersoll MA; Lutze RD; Keirns DL; Hunter WJ; Bashir K; Teitz T
J Am Soc Nephrol; 2024 Jan; 35(1):22-40. PubMed ID: 37962623
[TBL] [Abstract] [Full Text] [Related]
5. Case Report: Malignant melanoma in a patient with Crohn's disease treated with ustekinumab.
Axiaris G; Ioannou A; Papoutsaki M; Marinos L; Liontos M; Michopoulos S; Zampeli E
F1000Res; 2022; 11():424. PubMed ID: 37867623
[TBL] [Abstract] [Full Text] [Related]
6. Mutation in Chek2 triggers von Hippel-Lindau hemangioblastoma growth.
Cabrera-Montes J; Aguirre DT; Viñas-López J; Lorente-Herraiz L; Recio-Poveda L; Albiñana V; Pérez-Pérez J; Botella LM; Cuesta AM
Acta Neurochir (Wien); 2023 Dec; 165(12):4241-4251. PubMed ID: 37843608
[TBL] [Abstract] [Full Text] [Related]
7. Combined braf, MEK, and heat-shock protein 90 inhibition in advanced braf V600-mutant melanoma.
Eroglu Z; Chen YA; Smalley I; Li J; Markowitz JK; Brohl AS; Tetteh L; Taylor H; Sondak VK; Khushalani NI; Smalley KSM
Cancer; 2024 Jan; 130(2):232-243. PubMed ID: 37776537
[TBL] [Abstract] [Full Text] [Related]
8. SETD2 Deficiency Confers Sensitivity to Dual Inhibition of DNA Methylation and PARP in kidney Cancer.
Zhou X; Sekino Y; Li HT; Fu G; Yang Z; Zhao S; Gujar H; Zu X; Weisenberger DJ; Gill IS; Tulpule V; D'souza A; Quinn DI; Han B; Liang G
Cancer Res; 2023 Nov; 83(22):3813-3826. PubMed ID: 37695044
[TBL] [Abstract] [Full Text] [Related]
9. Comparative analysis of salvage partial nephrectomy versus radical nephrectomy after the failure of initial partial nephrectomy.
Huang J; Su R; Zhang C; Bao Y; Hu X; Ye X; Chen M; Wang P; Wu J; Wang Y; Tang Q; Huang Z; Zheng B; Li C; Guo J; Huang Y; Wei Q; He Z; Xue W
Urol Oncol; 2023 Oct; 41(10):434.e17-434.e25. PubMed ID: 37563078
[TBL] [Abstract] [Full Text] [Related]
10. Use of Virus Genotypes in Machine Learning Diagnostic Prediction Models for Cervical Cancer in Women With High-Risk Human Papillomavirus Infection.
Xiao T; Wang C; Yang M; Yang J; Xu X; Shen L; Yang Z; Xing H; Ou CQ
JAMA Netw Open; 2023 Aug; 6(8):e2326890. PubMed ID: 37531108
[TBL] [Abstract] [Full Text] [Related]
11. Metanephric stromal tumor in an adult with PDGFRA mutation: a case report.
Guo S; Qian H; Zhu H; Yang Y; Yang X; Sun H
Diagn Pathol; 2023 Jul; 18(1):83. PubMed ID: 37454137
[TBL] [Abstract] [Full Text] [Related]
12. Case report of a patient with Erdheim-Chester disease presenting with neuro-endocrine symptoms and negative for braf mutation.
Lu L; Zhou J; Yan X; Jin R; Deng S; Lu W; Chen D
Medicine (Baltimore); 2023 May; 102(20):e33846. PubMed ID: 37335698
[TBL] [Abstract] [Full Text] [Related]
13. Identification of braf, CCND1, and MYC mutations in a patient with multiple primary malignant tumors: a case report and review of the literature.
Liu Z; Jin C; Zhang Y; Jiang Y; Wang J; Zheng L
World J Surg Oncol; 2023 May; 21(1):158. PubMed ID: 37221610
[TBL] [Abstract] [Full Text] [Related]
14. Comparisons of different lymph node staging systems for predicting overall survival of node-positive patients with renal cell carcinoma: a retrospective cohort study using the Surveillance, Epidemiology and End Results database.
Zheng W; Jiang W; Wu Q; Chen J; Zhang Z; Yu S; Guo C
BMJ Open; 2023 Apr; 13(4):e068044. PubMed ID: 37185648
[TBL] [Abstract] [Full Text] [Related]
15. Incidence of urological cancers in neurological patients: a review of the literature from the EAU Young Academic Urologist Functional Group.
Cancrini F; Osman N; Doizi S; Guillot-Tantay C; Hüsch T; Illiano E; Tutolo M; Tienza A; Culha MG; Vale L; Raison N; Herve F; Grande P; Roupret M; Phé V
Minerva Urol Nephrol; 2023 Apr; 75(2):163-171. PubMed ID: 36999836
[TBL] [Abstract] [Full Text] [Related]
16. Possible Combined Effects of Plasma Folate Levels, Global DNA Methylation, and Blood Cadmium Concentrations on Renal Cell Carcinoma.
Huang CY; Chen WJ; Lee HL; Lin YC; Huang YL; Shiue HS; Pu YS; Hsueh YM
Nutrients; 2023 Feb; 15(4):. PubMed ID: 36839294
[TBL] [Abstract] [Full Text] [Related]
17. [A Case of Suspected Lynch Syndrome Due to Radical Resection for Descending Colon Cancer and Renal Pelvic Cancer].
Enoki Y; Kameyama H; Uehara H; Iwaya A; Yamazaki T; Ishii S; Takamatsu Y; Tomizawa G; Sudo N; Katada T; Kobayashi K; Sato D; Sakata E; Yokoyama N; Kuwabara S
Gan To Kagaku Ryoho; 2022 Dec; 49(13):1547-1549. PubMed ID: 36733130
[TBL] [Abstract] [Full Text] [Related]
18. Efficacy of Dabrafenib and Trametinib in a Patient with Squamous-Cell Carcinoma, with Mutation p.D594G in
Grenda A; Krawczyk P; Targowska-Duda KM; Kieszko R; Paśnik I; Milanowski J
Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36674722
[TBL] [Abstract] [Full Text] [Related]
19. Clinical phenotypes and long-term outcome of kidney involvement in Erdheim-Chester histiocytosis.
Chazal T; Pegoraro F; Manari G; Bettiol A; Maniscalco V; Gelain E; Charlotte F; Mazor RD; Renard-Penna R; Amoura Z; Cohen-Aubart F; Haroche J; Izzedine H; Vaglio A
Kidney Int; 2023 Jan; 103(1):177-186. PubMed ID: 36374823
[TBL] [Abstract] [Full Text] [Related]
20. A retrospective single-centered, comprehensive targeted genetic sequencing analysis of prognostic survival using tissues from Korean patients with metastatic renal cell carcinoma after targeted therapy.
Kim SH; Park J; Park WS; Hong D; Chung J
Investig Clin Urol; 2022 Nov; 63(6):602-611. PubMed ID: 36347549
[TBL] [Abstract] [Full Text] [Related]
[Next]
